Biotech Company - Rigvir Group

Stage IIA Skin Melanoma Treatment With ECHO-7 Oncolytic Virus Rigvir

In this report, the authors describe a patient with stage IIA skin melanoma treated with surgery and Rigvir virotherapy. Observations made more than 7 years after surgery indicated no signs of disease progression.

Melanoma is a global problem due to the rising numbers of skin melanoma cases. In this report, the authors describe a patient with stage IIA skin melanoma treated with surgery and Rigvir virotherapy. Observations made more than 7 years after surgery indicated no signs of disease progression.

Natural Intelligence Cancer Prevention Project

Rigvir group has made a decision to offer a fundamentally new approach to cancer prevention, that would allow to identify high cancer-risks timely and address them effectively, using the oncolytic virus Rigvir.

Henceforth, Rigvir virus is going to be developed also in the non-medical field which could provide preventive help to people with high cancer-risks or scientifically proven cancer presence in the body even before cancer can be diagnosed.

Natural Intelligence Cancer Prevention Project

Rigvir group has made a decision to offer a fundamentally new approach to cancer prevention.

More information

Promotional video

Shooting Star

To honour and thank Aina Muceniece – a scientist, oncologist, immunologist and virologist, as well as Rigvir inventor and founder of practical cancer virotherapy for the possibility to live a full life, Harijs Zariņš – a musician and poet, has composed a song called “Shooting Star”.

Watch video

Shooting Star

To honour and thank Aina Muceniece – a scientist, oncologist, immunologist and virologist, as well as Rigvir inventor and founder of practical cancer virotherapy for the possibility to live a full life, Harijs Zariņš – a musician and poet, has composed a song called “Shooting Star”.

Watch Video

“Another Taste of Life” film premiere on television

The movie tells us about 8 inspirational people affected by cancer gathering from all around the world to attempt the Mont Blanc. Movie is freely available in several languages on: www.anothertasteoflife.com

Go to website

A unique chronicle of Rigvir's development has been created on Instagram

Anyone interested can learn about the history of Rigvir's development from the very beginning to the present day on the Instagram and continue to follow all the most important Rigvir related news.

Go to Instagram

Rigvir group has signed a license agreement

Agreement was signed on the development, registration and sales of Rigvir medicine in the CIS region countries.

We Believe in the Good Virus

We invest in biomanufacturing and we focus on growing our portfolio of virotherapy medicines that meet the real needs of patients.

Products

Publication of New Toxicity study

4-Week repeated dose rat GLP toxicity study of oncolytic ECHO-7 virus Rigvir

The results show that there were no significant test item-related adverse events.
Based on the results, the no-observed-adverse-effect level (NOAEL) was considered to be the highest dose tested.

Rigvir Group is looking for partners globally

To finance the commercialization process of a next generation solution for unmet medical needs in oncology based on the existing product.

For Investors

Rigvir Group finalised an ERAF funded project - GLP Toxicity Study of Rigvir

The aims of the project have been reached, and as a result a NOAEL (no adverse effect level) has been determined.

GMP compliance certificate received

Rigvir's new API (Active pharmaceutical ingredient) center of manufacturing has received GMP (Good Manufacturing Practice) compliance certification for the production of Rigvir virus ECHO-7.